coronary artery disease
Conditions
Interventions
Aspirin group
Clopidogrel group
Sponsors
Osaka General Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Coronary artery disease patients implanted DES at our institute 2) Patients continuing DAPT after PCI 3) Patients capable of using OCT at the follow up CAG 4) Patients who received sufficient explanation, understood it and gave written consent based on their free will, before participating in this study
Exclusion criteria
Exclusion criteria: 1) Patients with cardiovascular shock 2) Patients with a history of stent thrombosis 3) Patients who is impossible to be followed up at our institute 4) Patients scheduled to have PCI or bypass surgery 5) Patients who are treated with thienopyridine for secondary prevention of cerebrovascular event 6) Pregnant or possibly pregnant 7) Life expectancy <1 year 8) Patients after PCI 9) Patients who were judged inappropriate by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of OCT parameter after switch to single antiplatelet treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Hemorrhagic event Stent thrombosis Major adverse cardiac event | — |
Countries
Japan
Contacts
Public ContactAtsushi Kikuchi
Osaka General Medical Center Department of Cardiology
Outcome results
None listed